Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study
Clinical & Translational Immunology2020Vol. 9(10), pp. e1192–e1192
Citations Over TimeTop 10% of 2020 papers
Ziyun Shao, Yongwen Feng, Li Zhong, Qifeng Xie, Ming Lei, Zheying Liu, Zheying Liu, Conglin Wang, Jingjing Ji, Huiheng Liu, Zhengtao Gu, Zhongwei Hu, Lei Su, Ming Wu, Zhifeng Liu, Zhifeng Liu
Abstract
Early administration of IVIG with high dose improves the prognosis of critical-type patients with COVID-19. This study provides important information on clinical application of IVIG in the treatment of SARS-CoV-2 infection, including patient selection and administration dosage and timing.
Related Papers
- → Birthweight and blood pressure in five European birth cohort studies: an investigation of confounding factors(2005)64 cited
- → Cancer mortality among shoe manufacturing workers: an analysis of two cohorts.(1996)69 cited
- → Profile of vitamin D in a cohort of physicians and diabetologists in Kolkata(2012)23 cited
- Evaluating the role of confounding in pharmacoeconomic studies.(2003)
- → Cohort profile: COVID-19 in a cohort of pregnant women and their descendants, the MOACC-19 study(2020)